Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% below its 1-year average of 25.00%, near the low end of its 1-year range (0.00%–100.00%).
100.00% below its 12-month average of 33.33%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
33.33%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Parabilis Medicines, Inc.
Market Cap
$3.36B
Gross Margin
0.00%
TTM Avg
33.33%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.38B
Gross Margin
91.13%
TTM Avg
91.57%
3Y Avg
93.72%
5Y Avg
94.38%
Market Cap
$3.31B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.44B
Gross Margin
-360.00%
TTM Avg
-180.00%
3Y Avg
-491.57%
5Y Avg
-334.18%
Market Cap
$3.48B
Gross Margin
-43.89%
TTM Avg
0.67%
3Y Avg
45.02%
5Y Avg
61.14%
Market Cap
$3.52B
Gross Margin
71.45%
TTM Avg
69.72%
3Y Avg
68.83%
5Y Avg
69.16%
Market Cap
$3.54B
Gross Margin
66.09%
TTM Avg
33.05%
3Y Avg
41.52%
5Y Avg
61.02%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Parabilis Medicines, Inc. (PBLS) | $3.36B | 0.00% | 33.33% | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 91.13% | 91.57% | 93.72% | 94.38% |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | 0.00% | 0.00% | 0.00% | 0.00% |
| CareDx, Inc (CDNA)vs › | $3.30B | 70.58% | 67.35% | 65.86% | 66.29% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | -360.00% | -180.00% | -491.57% | -334.18% |
| Celcuity Inc. (CELC)vs › | $3.47B | 0.00% | 0.00% | 0.00% | 0.00% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | -43.89% | 0.67% | 45.02% | 61.14% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | 71.45% | 69.72% | 68.83% | 69.16% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | 66.09% | 33.05% | 41.52% | 61.02% |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.19B | 90.59% | 93.09% | 93.34% | 78.29% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
